<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200301046655N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-13</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of fasting diet in sleeve surgery</public_title>
      <acronym></acronym>
      <scientific_title>Investigation the effect of intermittent fasting diet in comparison with calorie restriction diet on pre-, intra- and postoperative clinical outcomes in patients undergoing sleeve gastrectomy surgery: A clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71426</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this trial, the balanced random block method will be used, with a block size of 4 (combination of A and B as groups). Using the Randomization.com website, random allocation will be done for 60 people in the form of 15 blocks of 4. Since body mass index is an important variable in the intervention effect. This intervention will be implemented in a classified manner. In order to properly implement this trial, a random allocation list will be generated separately for each of the two classes of body mass index 40 to 45 and 45 to 50, Blinding description: the principal investigator, the surgeon, the anesthetist, the ward nurses, the person in charge of data collection and the person who evaluates the outcome will not know whether the type of diet received was intermittent fasting or calorie restriction.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sleeve gastrectomy surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intermittent fasting diet of 16:8 type (16 hours only allowed to receive water, non-energy drinks, tea, coffee and free consumption of food for 8 hours), in case of weakness or headache, it is explained to the participants that they should eat a snack consisting of 200 kilocalories of mixed nuts (18 grams of fat, 5 grams of protein, 4 grams of carbohydrates), in fact a low carbohydrate snack. This diet will be followed for 4 weeks before sleeve gastrectomy surgery. Intervention 2: Control group: The calorie restriction diet (after calculating the amount of calories required by the Mifflin method, in which the actual weight is in kilograms and height in centimeters based on the year, and by applying the coefficient of physical activity and calorific value of food, 25% of the total estimated calories will be reduced and the food plan will be adjusted for each person) will be observed for 4 weeks before the sleeve gastrectomy surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Razieh Khalooeifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sina Hospital, Hassan Abad Square, Imam Khomeini St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11367 46911</zip>
        <telephone>+98 21 6634 8500</telephone>
        <email>shkhalooei1367@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Razieh Khalooeifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sina Hospital, Hassan Abad Square, Imam Khomeini Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11367 46911</zip>
        <telephone>+98 21 6634 8500</telephone>
        <email>shkhalooei1367@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study
Body mass index ≥ 40
A candidate for elective sleeve gastrectomy surgery
American Society of Anesthesiology classification grade: 1-2</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Vegetarians
Previous history of bariatric surgery
Diabetics treated with insulin
People with uncontrolled high blood pressure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z98.84</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Bariatric surgery status</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intermittent fasting diet of 16:8 type (16 hours only allowed to receive water, non-energy drinks, tea, coffee and free consumption of food for 8 hours), in case of weakness or headache, it is explained to the participants that they should eat a snack consisting of 200 kilocalories of mixed nuts (18 grams of fat, 5 grams of protein, 4 grams of carbohydrates), in fact a low carbohydrate snack. This diet will be followed for 4 weeks before sleeve gastrectomy surgery.</i_keyword>
      <i_keyword>Control group: The calorie restriction diet (after calculating the amount of calories required by the Mifflin method, in which the actual weight is in kilograms and height in centimeters based on the year, and by applying the coefficient of physical activity and calorific value of food, 25% of the total estimated calories will be reduced and the food plan will be adjusted for each person) will be observed for 4 weeks before the sleeve gastrectomy surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Liver size. Timepoint: At the beginning of the study (before the start of the intervention) and before surgery. Method of measurement: sonography.</prim_outcome>
      <prim_outcome>Weight. Timepoint: At the beginning of the study (before the start of the intervention) and before surgery. Method of measurement: scales.</prim_outcome>
      <prim_outcome>Body mass index. Timepoint: At the beginning of the study (before the start of the intervention) and before surgery. Method of measurement: The ratio of weight (in kilograms) to the second power of height in meters.</prim_outcome>
      <prim_outcome>Lipid profile. Timepoint: At the beginning of the study (before the start of the intervention) and before surgery. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Liver enzymes. Timepoint: At the beginning of the study (before the start of the intervention) and before surgery. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Duration of anesthesia. Timepoint: From the time of the induction of anesthesia to extubation of the patient. Method of measurement: in minutes and from the patient's medical record.</prim_outcome>
      <prim_outcome>Duration of surgery. Timepoint: The duration of surgery from the time of prep and drape to the completion of suturing. Method of measurement: in minutes and from the patient's medical record.</prim_outcome>
      <prim_outcome>Duration of hospitalization. Timepoint: From the time of admission to the surgical department until discharge. Method of measurement: by day and through the patient's medical record.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-28</approval_date>
        <contact_name>Research Ethics committee of Sina Hospital</contact_name>
        <contact_address>Floor 13, Block A, Ministry of Health &amp; Medical Education Headquarters, Between Zarafashan &amp; South Falamak, Qods Town Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
